期刊文献+

地塞米松对妊娠期血小板减少综合征患者的PLT、LDH、AST、ALT及妊娠结局的影响 被引量:7

Effect of Dexamethasone on pregnancy outcome in patients with gestational thrombocytopenia syndrome
下载PDF
导出
摘要 目的研究地塞米松对妊娠期血小板减少综合征患者的血小板计数(PLT)、乳酸脱氢酶(LDH)、天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)及其妊娠结局的影响。方法将2014年3月至2015年4月在该院接受治疗的血小板减少综合征孕妇60例纳入观察组,根据其PLT减少程度分为Ⅰ级组、Ⅱ级组、Ⅲ级组,每组各20例,并选择同期60例健康孕妇作为对照组。给予观察组患者地塞米松治疗。对比两组孕妇及观察组中不同级别患者的PLT、LDH、AST、ALT的水平,以及并发症、妊娠结局、预后等情况。结果治疗后,观察组的PLT和LDH的水平均达到了正常的标准,与对照组比较,差异无统计学意义(P>0.05)。观察组患者的并发症发生率与围生儿死亡率明显高于对照组(P<0.05)。治疗后,观察组中Ⅰ级组的患者其血小板恢复时间为(4.78±1.45)d,明显高于Ⅲ级组患者的(2.82±0.86)d,差异有统计学意义(P<0.05)。其Ⅰ级组患者的不良妊娠结局(50.00%)均明显高于Ⅱ级组(25.00%)与Ⅲ级组(20.00%)的患者(P<0.05)。结论地塞米松治疗妊娠期血小板减少综合征,能够有效改善其不良的妊娠结局及患者的预后,但其疗效与临床分级有密切的关系。 Objective To study the effect of Dexamethasone on blood platelet count(PLT),lactate dehydrogenase(LDH),aspertate aminotransferase(AST),alanine aminotransferase(ALT)and pregnancy outcome in patients with gestational thrombocytopenia syndrome.Methods A total of 60 pregnant women with thrombocytopenia syndrome from March 2014 to April 2015 in our hospital were recruited into observation group,according to the platelet count,60 patients were divided into classⅠ,class Ⅱ and classⅢ group,20 cases in each group.Another 60 normal delivery of healthy pregnant women were recruited as control group.The patients of observation group were given Dexamethasone.The levels of PLT,LDH,AST,ALT,and complications,pregnant outcome,prognosis were compared in the two groups and gradeⅠ,gradeⅡand gradeⅢ group.Results After treatment,the PLT and LDH in the observation group recovered to the normal standard,which had no significant differences compared with those in the control subjects(P〉0.05).The complications and perinatal mortality in observation group were obviously higher than those in the control group(P〈0.05).After treatment,the recovery time of PLT of patients of gradeⅠin the observation group was(4.78±1.45)d,which was significant higher than(2.82±0.86)d of gradeⅢ patients(P〈0.05).The adverse pregnancy outcomes in patients with gradeⅠ group(50.00%)was significant higher than those of gradeⅡ group(25.00%)and the levelⅢ(20.00%)of the patients(P〈0.05).Conclusion Dexamethasone could effectively improve the adverse pregnancy outcomes and the prognosis of patients with gestational thrombocytopenia syndrome,but the curative effect has close relationship with clinical classification.
作者 马立苹 陈媛媛 张西艺 李维玲 MA Liping CHEN Yuanyuan ZHANG Xiyi LI Weiling(Department of Obstetrics and Gynecology ,GaoXin Hospital of Xi'an ,Xi'an ,Shaanxi 710075 ,China)
出处 《检验医学与临床》 CAS 2016年第19期2763-2765,2768,共4页 Laboratory Medicine and Clinic
关键词 地塞米松 妊娠期血小板减少综合征 妊娠结局 Dexamethasone gestational thrombocytopenia syndrome pregnancy outcomes
  • 相关文献

参考文献15

二级参考文献91

共引文献84

同被引文献66

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部